Investing.com - Revolution Medicines (NASDAQ:RVMD) is advancing its oncology pipeline with a strong focus on pancreatic ductal adenocarcinoma (PDAC), according to a new Stifel research note. The ...
Memorial Sloan Kettering Cancer Center researchers have found RNA neoantigen vaccines that generate long-lived, functional CD8 + T cells in patients with pancreatic ductal adenocarcinoma (PDAC), ...
MedPage Today on MSN
Regimen improves PFS in highly mutated metastatic colorectal cancer
But is the combination a "viable alternative" to nivolumab and ipilimumab?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results